Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1513525/000121390018012298/f10q0618_adialpharma.htm
SEC Filings
ADIL Annual Reports
ADIL Quarterly Reports
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report August 2019
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report August 2019
ADIL Corporate News
Financial Exhibit
New Agreement
Regulated Disclosure March 2023
Financial Exhibit
Other Events
Regulated Disclosure March 2023
Financial Exhibit
Listing Status March 2023
Financial Exhibit
Other Events February 2023
Financial Exhibit
New Agreement
Other Events
Unregistered Sales February 2023
Financial Exhibit
Other Events
Regulated Disclosure February 2023
Financial Exhibit
New Agreement
Regulated Disclosure February 2023
Earnings Release
Financial Exhibit November 2022
Event for Officers
Financial Exhibit
Vote of Security Holders October 2022
Financial Exhibit
Other Events
Regulated Disclosure September 2022
Financial Exhibit
New Agreement
Regulated Disclosure
New Agreement
Regulated Disclosure
March 2023
Financial Exhibit
Other Events
Regulated Disclosure
Other Events
Regulated Disclosure
March 2023
Financial Exhibit
Listing Status
Listing Status
March 2023
Financial Exhibit
Other Events
Other Events
February 2023
Financial Exhibit
New Agreement
Other Events
Unregistered Sales
New Agreement
Other Events
Unregistered Sales
February 2023
Financial Exhibit
Other Events
Regulated Disclosure
Other Events
Regulated Disclosure
February 2023
Financial Exhibit
New Agreement
Regulated Disclosure
New Agreement
Regulated Disclosure
February 2023
Earnings Release
Financial Exhibit
Financial Exhibit
November 2022
Event for Officers
Financial Exhibit
Vote of Security Holders
Financial Exhibit
Vote of Security Holders
October 2022
Financial Exhibit
Other Events
Regulated Disclosure
Other Events
Regulated Disclosure
September 2022
ADIL Registration of Securities
Last10K.com | 10-Q Quarterly Report Mon Sep 10 2018
Document and Entity Information - shares | 6 Months Ended | |
|---|---|---|
Jun. 30, 2018 | Sep. 06, 2018 | |
| Document And Entity Information | ||
| Entity Registrant Name | ADIAL PHARMACEUTICALS, INC. | |
| Entity Central Index Key | 0001513525 | |
| Amendment Flag | false | |
| Trading Symbol | ADIL | |
| Current Fiscal Year End Date | --12-31 | |
| Document Type | 10-Q | |
| Document Period End Date | Jun. 30, 2018 | |
| Document Fiscal Period Focus | Q2 | |
| Document Fiscal Year Focus | 2018 | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Common Stock, Shares Outstanding | 6,556,249 |
View differences made from one quarter to another to evaluate Adial Pharmaceuticals, Inc.'s financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Adial Pharmaceuticals, Inc..
Assess how Adial Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy
Adial Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Document And Entity Information
Condensed Balance Sheets (Unaudited)
Condensed Balance Sheets (Unaudited) (Parenthetical)
Condensed Statements Of Cash Flows (Unaudited)
Condensed Statements Of Cash Flows (Unaudited) (Parenthetical)
Condensed Statements Of Changes In Stockholders' Deficit (Unaudited)
Condensed Statements Of Operations (Unaudited)
Business
Commitments And Contingencies
Commitments And Contingencies (Details Textual)
Commitments And Contingencies (Details)
Commitments And Contingencies (Tables)
Convertible Notes
Convertible Notes (Details)
Derivative Liability
Derivative Liability (Details Textual)
Derivative Liability (Details)
Derivative Liability (Tables)
Income Taxes
Income Taxes (Details)
Related Party Transactions
Related Party Transactions (Details)
Senior Secured Notes
Senior Secured Notes (Details Textual 1)
Senior Secured Notes (Details Textual 2)
Senior Secured Notes (Details Textual)
Significant Accounting Policies
Significant Accounting Policies (Details Textual)
Significant Accounting Policies (Details)
Significant Accounting Policies (Policies)
Significant Accounting Policies (Tables)
Stockholders' Deficit
Stockholders' Deficit (Details 1)
Stockholders' Deficit (Details 2)
Stockholders' Deficit (Details Textual)
Stockholders' Deficit (Details)
Stockholders' Deficit (Tables)
Subordinated Notes - Related Parties
Subordinated Notes - Related Parties (Details)
Subsequent Events
Subsequent Events (Details)
Material Contracts, Statements, Certifications & more
Adial Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits
Ticker: ADIL
CIK: 1513525
Form Type: 10-Q Quarterly Report
Accession Number: 0001213900-18-012298
Submitted to the SEC: Fri Sep 07 2018 8:54:33 PM EST
Accepted by the SEC: Mon Sep 10 2018
Period: Saturday, June 30, 2018
Industry: Pharmaceutical Preparations
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/adil/0001213900-18-012298.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...